Related Experiment Videos
MR Imaging in the Follow-Up Evaluation of Aggressive Soft Tissue Tumors
Lorraine G. Shapeero1, Daniel Vanel
1Department of Radiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Abstract:
Although newer imaging techniques aid in the diagnosis of soft tissue sarcomas and current surgical procedures and adjunct therapy decrease the incidence of their recurrences when patients are referred to oncologic centers, the majority of these tumors are suboptimally evaluated in general practice with frequent recurrences. Close surveillance of these patients is necessary for early recognition and treatment of recurrent disease. This article describes an organized, stepwise magnetic resonance imaging evaluation of these patients after surgery and radiation therapy. The initial sequence should be T2-weighted. Low signal intensity or diffuse high signal intensity without mass on T2-weighted sequence excludes recurrence in 99% of patients. A high signal intensity mass, however, should be studied with bolus injection of contrast medium. Although standard contrast-enhanced MR imaging differentiates the non-enhancing hygroma or hematoma from the enhancing recurrence or pseudotumor, dynamic contrast-enhanced MR imaging is required to distinguish the rapidly enhancing recurrent tumor from the slowly enhancing pseudotumor of inflammation.
Insights
Close surveillance of soft tissue sarcoma patients post-treatment is crucial. Magnetic resonance imaging (MRI) protocols, starting with T2-weighted sequences, effectively detect recurrences, differentiating them from post-treatment changes.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Soft tissue sarcomas frequently recur, often due to suboptimal evaluation in general practice.
- While advanced treatments reduce recurrence, close patient surveillance remains essential for early detection and management.
- Magnetic resonance imaging (MRI) plays a vital role in monitoring patients post-surgery and radiation therapy.
Purpose of the Study:
- To describe a structured, stepwise MRI protocol for evaluating patients after soft tissue sarcoma treatment.
- To enhance the early recognition and timely treatment of recurrent soft tissue sarcoma.
- To differentiate tumor recurrence from post-treatment sequelae using advanced MRI techniques.
Main Methods:
- Implementation of a stepwise MRI evaluation protocol following soft tissue sarcoma treatment.
- Initial assessment using T2-weighted MRI sequences to screen for recurrence.
- Utilizing bolus contrast medium injection and dynamic contrast-enhanced MRI for further characterization of suspicious findings.
Main Results:
- T2-weighted sequences with low or diffuse high signal intensity without a mass effectively exclude recurrence in 99% of cases.
- Contrast-enhanced MRI is necessary for masses with high signal intensity on T2-weighted images.
- Dynamic contrast-enhanced MRI is crucial for distinguishing rapidly enhancing recurrent tumors from slowly enhancing inflammatory pseudotumors.
Conclusions:
- A systematic MRI approach, beginning with T2-weighted imaging, is highly effective for surveillance of soft tissue sarcoma patients.
- Advanced MRI techniques, including dynamic contrast enhancement, are indispensable for accurate differentiation of recurrence from benign post-treatment changes.
- Optimized MRI protocols can improve the management of soft tissue sarcoma by enabling early detection of recurrence.